MARKET ACCESS TRENDS ACROSS THE EU5: 2010 TO 2015
Dalal, N, Mycka, J, Dellamano, R, Lobb, W, Dellamano, L, Sagaydachnaya, O, Sudol, M, Mora, M
Published in Value in health (01.05.2016)
Published in Value in health (01.05.2016)
Get full text
Journal Article
REGULATORY APPROVAL TO PATIENT ACCESS: AN EVALUATION OF EU5 AND US NATIONAL TIMING DIFFERENCES - AN UPDATE (2009–2015)
Mycka, J, Dellamano, R, Lobb, W, Dalal, N, Dellamano, L, Sagaydachnaya, O, Mora, M, Sudol, M, Lue, J
Published in Value in health (01.05.2016)
Published in Value in health (01.05.2016)
Get full text
Journal Article
Regulatory Approval To Patient Access, An Evaluation of Eu5 And Us National Timing Differences: An Update
Mycka, J, Dellamano, R, Lobb, W, Dalal, N, Pereira, E, Dellamano, L, Sagaydachnaya, O
Published in Value in health (01.11.2014)
Published in Value in health (01.11.2014)
Get full text
Journal Article
Regulatory Approval to Patient Access, an Evaluation of EU5 and us National Timing Differences
Mycka, J, Dellamano, R, Lobb, W, Dalal, N, Pereira, E, Dellamano, L, Sagaydachnaya, O
Published in Value in health (01.11.2014)
Published in Value in health (01.11.2014)
Get full text
Journal Article
Timing of eu5 & US Orphan Drug approvals and PRMA between 2009 and 2013
Mycka, J, Dellamano, R, Lobb, W, Dalal, N, Pereira, E, Dellamano, L, Sagaydachnaya, O, Lue, J
Published in Value in health (01.05.2015)
Published in Value in health (01.05.2015)
Get full text
Journal Article
HPR55 Market Access Trends of Pharmaceutical Products in US, EU4 and UK (2016-2021)
Mycka, J.M., Dalal, N., Dellamano, R., Ashton, A., Pollere, D.
Published in Value in health (01.06.2023)
Published in Value in health (01.06.2023)
Get full text
Journal Article
P31 Impact of COVID-19 on HTA/PRMA of Medicinal Products in Europe: A Payer Perspective
Mycka, J, Dellamano, R, Lobb, W, Dalal, N, Dellamano, L, Pereira, E
Published in Value in health (01.01.2022)
Published in Value in health (01.01.2022)
Get full text
Journal Article
PMU38 Market Access Trends of Pharmaceutical Products in the EU5 and US (2009-2019)
Mycka, J.M., Dellamano, R., Lobb, W., Dalal, N., Dellamano, L., Pereira, E.
Published in Value in health (01.06.2021)
Published in Value in health (01.06.2021)
Get full text
Journal Article
PSY166 - MARKET ACCESS TRENDS FOR ADVANCED THERAPY MEDICINAL PRODUCTS (ATMPS) IN EUROPE
Dellamano, R., Mycka, J., Lobb, W., Dellamano, L., Dalal, N.
Published in Value in health (01.10.2018)
Published in Value in health (01.10.2018)
Get full text
Journal Article
PCN168 Lutetium (177LU) Oxodotreotide Versus Standard of Care in Adult Patients with Gastroenteropancreatic Neuroendocrine Tumours (GEP-NETS): A Cost-Consequences Analysis from an Italian Hospital Perspective
Spada, F., Campana, D., Lamberti, G., Laudicella, R., Dellamano, L., Dellamano, R., Baldari, S.
Published in Value in health (01.12.2020)
Published in Value in health (01.12.2020)
Get full text
Journal Article
PNS90 PROPOSED US INTERNATIONAL REFERENCE PRICING, POSSIBLE IMPACT
Mycka, J., Lobb, W., Dellamano, R., Dalal, N., Pereira, E., Dellamano, L.
Published in Value in health (01.05.2020)
Published in Value in health (01.05.2020)
Get full text
Journal Article
PMU54 A 10-YEAR REVIEW (2009-2018) OF MARKET ACCESS OF PHARMACEUTICALS IN THE EU5 AND US
Mycka, J., Dellamano, R., Lobb, W., Dalal, N., Dellamano, L., Pereira, E.
Published in Value in health (01.11.2019)
Published in Value in health (01.11.2019)
Get full text
Journal Article
PHP230 - EU5 MARKET ACCESS FOR MEDICINES APPROVED UNDER EXCEPTIONAL CIRCUMSTANCES
Mycka, J., Lobb, W., Dellamano, R., Dalal, N., Dellamano, L., Pereira, E.
Published in Value in health (01.10.2018)
Published in Value in health (01.10.2018)
Get full text
Journal Article
PHP229 - EU5 MARKET ACCESS FOR MEDICINES WITH CONDITIONAL MARKETING AUTHORISATIONS
Mycka, J., Dellamano, R., Lobb, W., Dalal, N., Dellamano, L., Pereira, E.
Published in Value in health (01.10.2018)
Published in Value in health (01.10.2018)
Get full text
Journal Article